244 related articles for article (PubMed ID: 31776265)
41. Immunologic and Virologic Parameters Associated With Human Immunodeficiency Virus (HIV) DNA Reservoir Size in People With HIV Receiving Antiretroviral Therapy.
Blazkova J; Whitehead EJ; Schneck R; Shi V; Justement JS; Rai MA; Kennedy BD; Manning MR; Praiss L; Gittens K; Wender PA; Oguz C; Lack J; Moir S; Chun TW
J Infect Dis; 2024 Jun; 229(6):1770-1780. PubMed ID: 38128541
[TBL] [Abstract][Full Text] [Related]
42. HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy.
Shahid A; Jones BR; Yang JSW; Dong W; Shaipanich T; Donohoe K; Brumme CJ; Joy JB; Leung JM; Brumme ZL
PLoS Pathog; 2022 Nov; 18(11):e1010613. PubMed ID: 36331974
[TBL] [Abstract][Full Text] [Related]
43. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.
Wang X; Xu H
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670027
[TBL] [Abstract][Full Text] [Related]
44. Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART.
Cochrane CR; Angelovich TA; Byrnes SJ; Waring E; Guanizo AC; Trollope GS; Zhou J; Vue J; Senior L; Wanicek E; Eddine JJ; Gartner MJ; Jenkins TA; Gorry PR; Brew BJ; Lewin SR; Estes JD; Roche M; Churchill MJ
Ann Neurol; 2022 Oct; 92(4):532-544. PubMed ID: 35867351
[TBL] [Abstract][Full Text] [Related]
45. The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
Joseph SB; Abrahams MR; Moeser M; Tyers L; Archin NM; Council OD; Sondgeroth A; Spielvogel E; Emery A; Zhou S; Doolabh D; Ismail SD; Karim SA; Margolis DM; Pond SK; Garrett N; Swanstrom R; Williamson C
PLoS Pathog; 2024 Feb; 20(2):e1011974. PubMed ID: 38422171
[TBL] [Abstract][Full Text] [Related]
46. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
[TBL] [Abstract][Full Text] [Related]
47. Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy.
White JA; Simonetti FR; Beg S; McMyn NF; Dai W; Bachmann N; Lai J; Ford WC; Bunch C; Jones JL; Ribeiro RM; Perelson AS; Siliciano JD; Siliciano RF
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35110411
[TBL] [Abstract][Full Text] [Related]
48. Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus.
Yucha R; Litchford ML; Fish CS; Yaffe ZA; Richardson BA; Maleche-Obimbo E; John-Stewart G; Wamalwa D; Overbaugh J; Lehman DA
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896832
[TBL] [Abstract][Full Text] [Related]
49. The HIV-2 proviral landscape is dominated by defective proviruses.
Koofhethile CK; Gao C; Chang C; Lian X; Shapiro R; Yu XG; Lichterfeld M; Kanki PJ
AIDS; 2024 Mar; 38(3):309-316. PubMed ID: 37916471
[TBL] [Abstract][Full Text] [Related]
50. HIV evolution and diversity in ART-treated patients.
van Zyl G; Bale MJ; Kearney MF
Retrovirology; 2018 Jan; 15(1):14. PubMed ID: 29378595
[TBL] [Abstract][Full Text] [Related]
51. Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir.
Kumar MR; Fray EJ; Bender AM; Zitzmann C; Ribeiro RM; Perelson AS; Barouch DH; Siliciano JD; Siliciano RF
Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2313209120. PubMed ID: 37844236
[TBL] [Abstract][Full Text] [Related]
52. The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.
McMyn NF; Varriale J; Fray EJ; Zitzmann C; MacLeod H; Lai J; Singhal A; Moskovljevic M; Garcia MA; Lopez BM; Hariharan V; Rhodehouse K; Lynn K; Tebas P; Mounzer K; Montaner LJ; Benko E; Kovacs C; Hoh R; Simonetti FR; Laird GM; Deeks SG; Ribeiro RM; Perelson AS; Siliciano RF; Siliciano JM
J Clin Invest; 2023 Sep; 133(17):. PubMed ID: 37463049
[TBL] [Abstract][Full Text] [Related]
53. Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection.
Uprety P; Patel K; Karalius B; Ziemniak C; Chen YH; Brummel SS; Siminski S; Van Dyke RB; Seage GR; Persaud D;
Clin Infect Dis; 2017 Jun; 64(11):1471-1478. PubMed ID: 28329153
[TBL] [Abstract][Full Text] [Related]
54. Relationship between intact HIV-1 proviruses in circulating CD4
Lu CL; Pai JA; Nogueira L; Mendoza P; Gruell H; Oliveira TY; Barton J; Lorenzi JCC; Cohen YZ; Cohn LB; Klein F; Caskey M; Nussenzweig MC; Jankovic M
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11341-E11348. PubMed ID: 30420517
[TBL] [Abstract][Full Text] [Related]
55. Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.
Liang EC; Sceats L; Bayless NL; Strauss-Albee DM; Kubo J; Grant PM; Furman D; Desai M; Katzenstein DA; Davis MM; Zolopa AR; Blish CA
J Virol; 2014 Aug; 88(15):8629-39. PubMed ID: 24850730
[TBL] [Abstract][Full Text] [Related]
56. Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.
Pinzone MR; O'Doherty U
Retrovirology; 2018 Feb; 15(1):22. PubMed ID: 29452580
[TBL] [Abstract][Full Text] [Related]
57. Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART.
Dufour C; Ruiz MJ; Pagliuzza A; Richard C; Shahid A; Fromentin R; Ponte R; Cattin A; Wiche Salinas TR; Salahuddin S; Sandstrom T; Schinkel SB; Costiniuk CT; Jenabian MA; Ancuta P; Routy JP; Cohen ÉA; Brumme ZL; Power C; Angel JB; Chomont N
Cell Rep; 2023 Sep; 42(9):113053. PubMed ID: 37676762
[TBL] [Abstract][Full Text] [Related]
58. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
[TBL] [Abstract][Full Text] [Related]
59. Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes.
Fisher K; Wang XQ; Lee A; Morcilla V; de Vries A; Lee E; Eden JS; Deeks SG; Kelleher AD; Palmer S
J Virol; 2022 Mar; 96(6):e0201121. PubMed ID: 35201897
[TBL] [Abstract][Full Text] [Related]
60. Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.
Wang XQ; Zerbato JM; Avihingsanon A; Fisher K; Schlub T; Rhodes A; Audsley J; Singh KP; Zhao W; Lewin SR; Palmer S
J Virol; 2022 Aug; 96(16):e0058822. PubMed ID: 35916523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
